Short Oxoproline-Containing Peptides as Potential Pharmacological Means of Hypolipidemic and Antithrombotic Actions

  • N. F. Myasoedov
  • L. A. LyapinaEmail author
  • L. A. Andreeva
  • T. Yu. Obergan
  • M. E. Grigoryeva
  • T. A. Shubina


The search and research of pharmacological agents that could combine lipid-lowering and antithrombotic effects on the human organism are one of the most urgent and important tasks of modern biological and medical research. The unique effects of the regulatory peptides of the oxoproline series (5-охо-Pro- His-Pro-NH2, 5-oxo-Pro-Trp-Pro, and 5-oxo-Pro-Arg-Pro or Pyr-His-Pro-NH2, Pyr-Trp-Pro, and Pyr- Arg-Pro) synthesized by the methods of classical peptide chemistry have been found in animals with experimental hypercholesterolemia. Repeated intranasal administration of these peptides to animals with developed hypercholesterolemia increased their anticoagulant, fibrinolytic and antiplatelet potential of the blood and simultaneously lowered increased concentrations of total cholesterol, low-density lipoprotein cholesterol, and triglycerides. In addition, they promoted normalization of blood glucose. A week after the last administration of these peptides, the hypocholesterolemic, normoglycemic and anticoagulant effects persisted. The relationship between the structure of the oxoproline-containing peptides and their functional properties is discussed. It is concluded that further studies of oxoproline-containing peptides are promising in the context of development of pharmacological agents, combining the antithrombotic activity with the improvement of lipid metabolism in the body.


oxoproline peptides hypocholesterolemic action antithrombotic activity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lun’shina, E.V., Gan’shina, T.S., Makarova, L.M., Pogorelyi, V.E., and Mirzoyan, R.S., Eksper. Klin. Farmakol., 2003, vol. 66, no. 1, pp. 20–22.Google Scholar
  2. 2.
    Kong, X., Zhang, D.Y., Wu, H.B., and Li, F.X., Biol. Pharm. Bull., 2011, vol. 34, no. 5, pp. 693–699.CrossRefGoogle Scholar
  3. 3.
    Vila, L., Rebollo, A., Adalsteisson, G.S., Alegre, T.M., Merlos, M., Roglans, N., and Laguna, J.C., Toxicol. Appl. Pharmacol., 2011, vol. 251, no. 1, pp. 32–40.CrossRefGoogle Scholar
  4. 4.
    Khavinson, V.Kh., Ryzhak, G.A., Lin’kova, N.S., Ashapkin, V.V., Drobintseva, A.O., Basharina, V.S., and Vanyushin, B.F., Molek. Med., 2014, no. 6, pp. 14–20.Google Scholar
  5. 5.
    Shataeva, L.K., Khavinson, V.Kh., and Ryadnova, I.Yu., Peptidnaya samoregulyatsiya zhivykh sistem (fakty i gipotezy) (Peptide Regulation of Living Systems: Facts and Hypotheses), Saint-Petersburg: Nauka, 2003.Google Scholar
  6. 6.
    Ashmarin, I.P., Lyapina, L.A., Andreeva, L.A., Ul’yanov, A.M., Pastorova, V.E., Obergan, T.Yu., Alfeeva, L.Yu., and Myasoedov, N.F., Tromboz, gemostaz i reologiya, 2008, vol. 34, no. 2, pp. 38–43.Google Scholar
  7. 7.
    Myasoedov, N.F., Andreeva, L.A., Lyapina, L.A., Ul’yanov, A.M., Shubina, T.A., Obergan, T.Yu., Pastorova, V.E., and Grigor’eva, M.E., Dokl. Biol. Sci., 2011, vol. 438, no. 2, pp. 1–4.Google Scholar
  8. 8.
    Ferrell, J.E. and Martin, G.S., Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 2234–2238.CrossRefGoogle Scholar
  9. 9.
    Myasoedov, N.F., Lyapina, L.A., Grigorjeva, M.E., Obergan, T.Y., Shubina, T.A., and Andreeva, L.A., Pathophysiology, 2016, vol. 23, no. 1, pp. 27–33.CrossRefGoogle Scholar
  10. 10.
    Martsevich, S.Yu., Ateroskleroz. Klinicheskaya znachimost’ i vozmozhnost’ preduprezhdeniya (Atherosclerosis. Clinical Importance and Possibility of Prevention), Moscow: Serviscom, 2005.Google Scholar
  11. 11.
    Xiao, C., Hsieh, J., Adeli, K., and Lewis, G.F., Am. J. Physiol. Endocrinol. Metab., 2011, vol. 301, pp. E429–E446.CrossRefGoogle Scholar
  12. 12.
    Gorbachisky, I., Akpinar, H., and Assimos, D.G., Rev. Urol., 2010, vol. 12, no. 4, pp. 157–180.Google Scholar
  13. 13.
    Barkagan, Z.S. and Kostyuchenko, G.I., Byull. SO RAMN, 2006, no. 2, pp. 132–138.Google Scholar
  14. 14.
    Watson, T., Arya, A., Sulke, N., and Lip, G.Y.H., Chest, 2010, vol. 137, pp. 869–876.CrossRefGoogle Scholar
  15. 15.
    Burov, S.V., Moskalenko, Yu.E., and Panarin, E.F., Zhurn. Org. Khimii, 2006, vol. 76, no. 4, pp. 700–702.Google Scholar
  16. 16.
    Shevchenko, K.V., V’yunova, T.V., Radilov, A.S., Andreeva, L.A., Nagaev, I.Yu., Shevchenko, V.P., Rembovsky, V.R., and Myasoedov, N.F., Dokl. Biochem. Biophys, 2015, vol. 465, no. 6, pp. 749–752. doi 10.7868/S0869565215360268Google Scholar
  17. 17.
    V’yunova, T.V., Andreeva, L.A., Shevchenko, K.V., Shevchenko, V.P., and Myasoedov, N.F., Neurochem. J., 2016, vol. 33, no. 3, pp. 230–237. doi 10.7868/S1027813316030134Google Scholar
  18. 18.
    Myasoedov, N.F., Shubina, T.A., Obergan, T.Yu., Grigor’eva, M.E., Andreeva, L.A., and Lyapina, L.A., Vopr. Pitaniya, 2013, vol. 82, no. 5, pp. 41–45.Google Scholar
  19. 19.
    Lyapina, L.A., Grigor’eva, M.E., Obergan, T.Yu., and Shubina, T.A., Teoreticheskie i prakticheskie voprosy izucheniya funktsional’nogo sostoyaniya protivosvertyvayushchei sistemy krovi (Theoretical and Practical Aspects of the Study of the Functional State of the Blood Anticoagulant System), Moscow: Advanced Solutions, 2012.Google Scholar
  20. 20.
    Kuznik, B.I., Khavinson, V.Kh., Tarnovskaya, S.I., and Lin’kova, N.S., Vestnik Gematol., 2013, vol. 9, no. 2, pp. 29–33.Google Scholar
  21. 21.
    Vasilijević, A., Buzadžić, B., Korać, A., Petrović, V., Janković, A., and Korać, B., J. Physiol., 2007, vol. 584, no. 3, pp. 921–933.CrossRefGoogle Scholar
  22. 22.
    Hasan, A.A., Wernock, M., Nieman, M., Srikanth, S., Mahdi, F., Krishnan, R., Tulinsky, A., and Schmaier, A., Am. J. Physiol. Heart Circ. Physiol., 2003, vol. 285, no. 1, pp. 183–193.CrossRefGoogle Scholar
  23. 23.
    Korkushko, O.V., Chizhova, V.P., Shatilo, V.B., and Khavinson, V.Kh., Usp. Gerontol., 2013, vol. 26, no. 2, pp. 297–308.Google Scholar
  24. 24.
    Solomon, J.K. and Geison, R.L., J. Nutrition, 1978, vol. 108, pp. 936–943.CrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2018

Authors and Affiliations

  • N. F. Myasoedov
    • 1
  • L. A. Lyapina
    • 2
    Email author
  • L. A. Andreeva
    • 1
  • T. Yu. Obergan
    • 2
  • M. E. Grigoryeva
    • 2
  • T. A. Shubina
    • 2
  1. 1.Institute of Molecular Genetics of Russian Academy of SciencesMoscowRussia
  2. 2.Faculty of BiologyMoscow State UniversityMoscowRussia

Personalised recommendations